Dow survives another Bayer patent challenge
Dow Chemical Company subsidiary Dow AgroSciences has won another lawsuit involving its Enlist weed control technology.
Andrulis sues Celgene over cancer patent
Andrulis Pharmaceuticals Corp has accused Celgene Corp of infringing and inducing the infringement of one of its patents related to a method of treating cancer.
23andMe’s ‘designer baby’ patent sparks controversy
Personal genomics company 23andMe has received a patent covering its Family Traits Inheritance Calculator tool that lets prospective parents see what traits their children may inherit.
Teva wins Netherlands Copaxone case
Teva Pharmaceutical Industries has claimed victory in a patent revocation action brought by generic drug maker Mylan in the Hague over its blockbuster Copaxone drug, used in the treatment of multiple sclerosis.
Vinge raids Lindahl ... again
Swedish law firm Vinge has hired IP specialist Ulf Dahlgren to its Stockholm office from rivals Lindahl, following Håkan Borgenhäll’s move from the same firm in April.
FTC restricts Mylan’s acquisition of Agila amid antitrust fears
Mylan Inc will be forced to divest injectable generic drugs before it can complete a proposed $1.85 billion acquisition of Agila Specialities Global Pte Ltd and Agila Specialties Pvt Ltd after the FTC applied conditions to the deal.
Baker Botts strengthens Houston patent practice
US law firm Baker Botts has expanded its Houston office with the addition of IP litigator Nicolas Barzoukas.
India urged to improve its drugs patent policy
India’s drug patent policy has been slammed by US companies who are insisting that action be taken in order to improve trade relations.
Judge denies AstraZeneca’s bid to squash pay-for-delay challenge
A federal judge has denied AstraZeneca’s motions to dismiss claims challenging its pay-for-delay deals with three generic pharmaceutical companies in connection to heartburn drug Nexium.
MyMedicalRecords sues over online health checks
A US company which provides secure personal medical records online has filed a patent infringement case against a rival health-care company.
